Jesús Pintor Selected Research

Corneal Neovascularization

1/2022

Therapeutic potential of topical administration of siRNAs against HIF-1α for corneal neovascularization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jesús Pintor Research Topics

Disease

22	Glaucoma 01/2020 - 01/2003
15	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021 - 09/2006
8	Ocular Hypertension (Glaucoma, Suspect) 01/2020 - 01/2005
4	Achondroplasia 06/2011 - 08/2007
3	Wounds and Injuries (Trauma) 01/2022 - 06/2009
3	Inflammation (Inflammations) 09/2017 - 01/2014
2	Aniridia 11/2016 - 08/2015
2	Sjogren's Syndrome (Sjogren Syndrome) 11/2016 - 11/2010
2	Keratoconus 10/2016 - 02/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 01/2014
2	Dwarfism 06/2011 - 03/2008
1	Hypoxia (Hypoxemia) 01/2022
1	Burns 01/2022
1	Corneal Neovascularization 01/2022
1	Hyperemia 01/2020
1	Neuroinflammatory Diseases 01/2018
1	Cognitive Dysfunction 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Myopia 01/2015
1	Hypersensitivity (Allergy) 11/2014
1	Neuroblastoma 11/2014
1	Endophthalmitis (Ophthalmia) 01/2014
1	Uveitis 01/2014
1	Hyperammonemia 01/2014
1	Tauopathies 01/2014
1	Eye Diseases (Eye Disease) 03/2013
1	Optic Nerve Diseases (Optic Neuropathy) 01/2013
1	Asthma (Bronchial Asthma) 04/2010
1	Retinal Detachment (Retinal Detachments) 07/2008
1	Infections 07/2008
1	Ganglion Cysts (Ganglion) 07/2008

Drug/Important Bio-Agent (IBA)

8	MelatoninIBA 01/2020 - 12/2006
8	NucleotidesIBA 01/2018 - 01/2005
8	diadenosine tetraphosphateIBA 01/2017 - 01/2003
6	5- methoxycarbonylamino- N- acetyltryptamineIBA 10/2019 - 12/2007
6	PolyphosphatesIBA 11/2016 - 09/2006
4	Adenosine Triphosphate (ATP)IBA 01/2017 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2022 - 05/2009
3	SecretagoguesIBA 01/2021 - 09/2016
3	MucinsIBA 01/2020 - 04/2008
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2009
3	Biomarkers (Surrogate Marker)IBA 11/2016 - 09/2006
3	Retinaldehyde (Retinal)IBA 01/2015 - 07/2008
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 11/2014
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2017
2	agomelatine (S20098)IBA 10/2019 - 02/2013
2	Purinergic P2Y2 ReceptorsIBA 01/2017 - 11/2016
2	Purinergic Receptors (Receptors, Purine)IBA 01/2017 - 01/2014
2	P(1),P(5)- di(adenosine- 5'- )pentaphosphateIBA 10/2016 - 09/2006
2	Pharmaceutical PreparationsIBA 09/2016 - 07/2013
2	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2013 - 09/2011
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 06/2011 - 03/2008
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2008 - 08/2007
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2020
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Dopamine D3 ReceptorsIBA 01/2020
1	IIK7IBA 10/2019
1	Lubricant Eye Drops (Artificial Tears)IBA 10/2019
1	Purinergic P2X7 ReceptorsIBA 01/2019
1	Purinergic P2Y ReceptorsIBA 01/2018
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2017
1	ChloridesIBA 11/2016
1	LubricantsIBA 09/2016
1	Heptanol (1 Heptanol)IBA 01/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2015
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2014
1	PyrophosphatasesIBA 11/2014
1	EnzymesIBA 01/2014
1	tau Proteins (tau Protein)IBA 01/2014
1	CF101IBA 01/2014
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2014
1	Purinergic P2 Receptors (ADP Receptor)IBA 01/2014
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2014
1	Purinergic AgonistsIBA 01/2014
1	Neuroprotective AgentsIBA 07/2013
1	trabecular meshwork-induced glucocorticoid response proteinIBA 01/2013
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2011
1	PolymersIBA 03/2011
1	Timolol (Blocadren)FDA LinkGeneric 04/2010
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2009
1	ParasympathomimeticsIBA 05/2009
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 05/2009
1	Cholinergic AgonistsIBA 04/2008
1	Terpenes (Terpenoids)IBA 04/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2008
1	Gefarnate (Ulco)IBA 04/2008
1	cevimeline (Evoxac)FDA Link 04/2008
1	Uridine Diphosphate (UDP)IBA 01/2008
1	Adenine NucleotidesIBA 01/2005

Therapy/Procedure

3	Contact Lenses 10/2016 - 03/2013
3	Therapeutics 09/2016 - 07/2008
2	Slit Lamp 01/2022 - 01/2015
1	Topical Administration 01/2022
1	Anesthesia 01/2020
1	Refractive Surgical Procedures 11/2016
1	Lenses 02/2016
1	Laser In Situ Keratomileusis (LASIK) 01/2015